Joseph M. Palumbo MD - 28 Aug 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Reporting relationship: Chief Medical Officer
Issuer ticker: BIVI
Reported as of: 28 Aug 2026
Net transaction value: +$10,461
SEC form: 4
Accepted by SEC: 28 Aug 2026, 21:01:49 UTC
Prior SEC filing: 09 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Joanne Wendy Kim, attorney-in-fact for Joseph M Palumbo, MD

Key filing fact

Joseph M. Palumbo MD filed Form 4 for BIOVIE INC. (BIVI) on 28 Aug 2026.

Key facts

This page summarizes Joseph M. Palumbo MD's Form 4 filing for BIOVIE INC. (BIVI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Aug 2026, 21:01.

Change

Previous filing in this sequence was filed on 09 Jan 2026.
Current net transaction value: +$10,461.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001892610 Primary reporting owner

Palumbo Joseph M

Relationship: Chief Medical Officer
Address: C/O BIOVIE INC., 680 W NYE LANE STE 201, CARSON CITY
Signature: /s/ Joanne Wendy Kim, attorney-in-fact for Joseph M Palumbo, MD
Signature date: 28 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIVI transaction

Common Stock

Purchase

Transaction value: $10,461
Shares: +4,843
Change %: +406%
Price: $2.16
Shares after: 6,036
Date: 28 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares of Common Stock were purchased in several open market transactions, all at the same price. The reported price does not reflect a weighted average price.